Related Experiment Video
Updated: May 1, 2026

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
3.2K
Two cases of malignant glaucoma unresolved by pars plana vitrectomy
Yoshikatsu Hosoda1, Tadamichi Akagi1, Nagahisa Yoshimura1
1Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Clinical Ophthalmology (Auckland, N.Z.)
|April 15, 2014
Summary
Malignant glaucoma refractory to vitrectomy may respond to peripheral iridectomy and zonulectomy. These minimally invasive procedures offer successful intraocular pressure control in challenging cases.
Area of Science:
- Ophthalmology
- Glaucoma Research
Background:
- Malignant glaucoma (MG) presents with a shallow anterior chamber and elevated intraocular pressure (IOP).
- Pars plana vitrectomy with anterior hyaloidectomy is the standard treatment for MG.
- Refractory cases of MG pose a significant clinical challenge.
Purpose of the Study:
- To report two cases of malignant glaucoma refractory to standard surgical management.
- To evaluate the efficacy of peripheral iridectomy with or without local zonulectomy in refractory MG.
Main Methods:
- Case report of two patients with pseudoexfoliation glaucoma who developed refractory malignant glaucoma.
- Surgical interventions included pars plana vitrectomy, peripheral iridectomy, local zonulectomy, goniosynechialysis, and trabectome surgery.
Main Results:
- Both patients achieved successful IOP control after undergoing peripheral iridectomy combined with other procedures.
- One patient required peripheral iridectomy and local zonulectomy after recurrence post-vitrectomy.
- The second patient underwent peripheral iridectomy, goniosynechialysis, and trabectome surgery for refractory MG.
Conclusions:
- Peripheral iridectomy with or without local zonulectomy is a viable surgical option for malignant glaucoma refractory to vitrectomy.
- These procedures represent a minimally invasive approach for managing complex glaucoma cases.
- Successful IOP management was achieved in challenging malignant glaucoma scenarios.
Related Concept Videos
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

